July 9, 2014
Lynda Dee of the Fair Pricing Coalition (FPC) spoke with coworkers Jeff Berry and Murray Penner, as well as David Evans of Project Inform, about access to HIV and hepatitis C (HCV) medications. FPC negotiates with pharmaceutical companies to make these drugs affordable for patients. Ongoing programs include a co-pay card that will cover medication co-payments and a patient assistance program for people without health insurance. In response to the Affordable Care Act (ACA), a third program is intended to cover coinsurance payments or deductibles for the ACA-sponsored Bronze plans. However, government agencies still disagree about whether such coverage will be permitted. Also mentioned was the fact that some HIV and HCV medications are not on insurance companies' lists of drugs they cover (so-called formularies). The panelists asked viewers to advocate with their local members of Congress around some of these issues.
Watch the video to learn more:
About the panelists:
The video above has been posted on TheBodyPRO.com with permission from our partners at the International Foundation for Alternative Research in AIDS (IFARA). Visit IFARA's website or YouTube channel to watch more video interviews from the conference, as well as earlier meetings.
Barbara Jungwirth is a freelance writer and translator based in New York.
Follow Barbara on Twitter: @reliabletran.
No comments have been made.
|Really Rapid Review -- AIDS 2016, Durban|
|Update on Genetic Engineering for an HIV Cure|
|Charlize Theron's 8 Quotable Moments About HIV at AIDS 2016|
|This Week in HIV Research: New Protein Could Shock and Kill Latent HIV, and Engineered T Cells Could Help Fight HIV|
|At AIDS 2016, the Global Village Rocks -- and Activists Party Without Pants|